Africa carries a high burden of infectious diseases. Every year, millions of Africans contract tuberculosis, malaria, and many other diseases. Malaria kills hundreds of thousands of children under the age of five years annually. More than 11,000 people died during the 2014–2016 Ebola outbreak in West Africa; still, occasional cases of Ebola, as well as monkeypox, periodically appear in the Democratic Republic of Congo. Since most of the African countries gained their independence during the 1960s, the continent has relied heavily on the outside world for diagnostics, medicines, vaccines, personal protective equipment, and other medical supplies. Africa consumes nearly 25% of the globally produced vaccines but imports 99% and 95% of its vaccines and medicines, respectively. The 55 African countries were not able to ensure the health of 1.3 billion Africans during the COVID-19 pandemic but had to rely on other global initiatives and other countries for help and support. However, the pandemic and the shortage of vaccines may have been the much-needed trigger for this situation to change. “When misfortunes increase, they erase each other.” Naguib Mahfouz (1911–2006).

中文翻译：

---

加强非洲的疫苗和药品制造能力：挑战和前景

非洲的传染病负担很重。每年，数百万非洲人感染肺结核、疟疾和许多其他疾病。疟疾每年导致数十万五岁以下儿童死亡。2014-2016 年西非埃博拉疫情期间，超过 11,000 人死亡；尽管如此，偶尔的埃博拉病例和猴痘病例仍会定期出现在刚果民主共和国。自从大多数非洲国家在 1960 年代获得独立以来，非洲大陆在诊断、药物、疫苗、个人防护设备和其他医疗用品方面严重依赖外部世界。非洲消费了全球近 25% 的疫苗，但分别进口 99% 和 95% 的疫苗和药品。55个非洲国家无法确保1人的健康。在 COVID-19 大流行期间有 30 亿非洲人，但不得不依靠其他全球倡议和其他国家的帮助和支持。然而，大流行和疫苗短缺可能是改变这种情况的急需触发因素。“当不幸增加时，它们会相互消除。”纳吉布·马福兹 (1911–2006)。